Mutual of America Capital Management LLC Decreases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mutual of America Capital Management LLC decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,653 shares of the company’s stock after selling 1,998 shares during the period. Mutual of America Capital Management LLC’s holdings in GE HealthCare Technologies were worth $4,181,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently made changes to their positions in GEHC. 9258 Wealth Management LLC lifted its position in shares of GE HealthCare Technologies by 5.7% during the 4th quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock valued at $253,000 after buying an additional 176 shares in the last quarter. Principal Securities Inc. purchased a new position in GE HealthCare Technologies in the 4th quarter valued at $38,000. Corient Private Wealth LLC lifted its holdings in GE HealthCare Technologies by 20.8% in the 4th quarter. Corient Private Wealth LLC now owns 69,073 shares of the company’s stock valued at $5,341,000 after purchasing an additional 11,907 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its holdings in GE HealthCare Technologies by 23.7% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 97,127 shares of the company’s stock valued at $7,510,000 after purchasing an additional 18,634 shares in the last quarter. Finally, US Bancorp DE lifted its holdings in GE HealthCare Technologies by 83.4% in the 4th quarter. US Bancorp DE now owns 146,524 shares of the company’s stock valued at $11,329,000 after purchasing an additional 66,638 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on GEHC shares. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. The Goldman Sachs Group started coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price objective on the stock. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Stifel Nicolaus started coverage on GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective on the stock. Finally, JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $95.00.

GE HealthCare Technologies Stock Down 0.4 %

Shares of NASDAQ:GEHC opened at $90.28 on Monday. The business has a 50-day moving average price of $84.06 and a 200 day moving average price of $83.21. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $41.21 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 3.26 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the company earned $0.92 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s payout ratio is 3.51%.

Insider Buying and Selling

In related news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.